Canada - December 3 2009 The Court of Appeal denied BIOTEC Canada’s and Eli Lilly’s leave to intervene in Pfizer’s appeal of the Court’s decision to invalidate a patent for amlodipine.
Canada - December 3 2009 ratiopharm was successful in the proceeding under the NOC Regulations at the trial level, but the decision was overturned on appeal.
Canada - November 24 2009 In a recent decision pursuant to the NOC Regulations, the Federal Court considered s. 73(1) of the Patent Act, and held that there is a duty for patent agents to reply in good faith and make full and frank disclosure to the patent examiner.
Canada - November 2 2009 Sanofi was seeking judicial review of an interlocutory decision of the Board, which was made during the course of dealings that had lasted a number of years.
Canada - November 2 2009 After a trial on the merits, the Court found that the patent at issue was invalid as it is not a valid selection patent.